PharmaShots | Incisive News in 3 Shots

Subscribe Now

Macular Degeneration

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

October 25, 2021

Roche Report the US FDA's Acceptance of BLA for Port Delivery System with Ranibizumab to Treat Neovascular Age-Related Macular Degeneration

Roche Report the US FDA's Acceptance of BLA for Port Delivery System with Ranibizumab to Treat Neovascular Age-Related Macular Deg...

June 24, 2021

Samsung Bioepis Reports Results of SB11 (proposed biosimilar ranibizumab) in P-III Study for Neovascular Age-Related Macular Degeneration

Samsung Bioepis Reports Results of SB11 (proposed biosimilar ranibizumab) in P-III Study for Neovascular Age-Related Macular Degen...

May 19, 2020

Novartis' Beovu (brolucizumab) Receives EC's Approval for Wet Age-Related Macular Degeneration

Novartis' Beovu (brolucizumab) Receives EC's Approval for Wet Age-Related Macular Degeneration

February 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us